Cargando…
Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization
Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naïve chronically infected Indian patient (ID50 >600-fold higher compared to other aut...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463516/ https://www.ncbi.nlm.nih.gov/pubmed/23056416 http://dx.doi.org/10.1371/journal.pone.0046713 |
_version_ | 1782245296814686208 |
---|---|
author | Ringe, Rajesh Das, Lipsa Choudhary, Ipsita Sharma, Deepak Paranjape, Ramesh Chauhan, Virander Singh Bhattacharya, Jayanta |
author_facet | Ringe, Rajesh Das, Lipsa Choudhary, Ipsita Sharma, Deepak Paranjape, Ramesh Chauhan, Virander Singh Bhattacharya, Jayanta |
author_sort | Ringe, Rajesh |
collection | PubMed |
description | Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naïve chronically infected Indian patient (ID50 >600-fold higher compared to other autologous env clones). The enhanced autologous neutralization of pseudotyped viruses expressing the sensitive envelope (Env) was associated with increased sensitivity to reagents and monoclonal antibodies targeting distinct sites in Env. Chimeric viruses constructed by swapping fragments of sensitive Env into resistant Env backbone revealed that the presence of unique residues within C2V3 region of gp120 governed increased neutralization. The enhanced virus neutralization was also associated with low CD4 dependence as well as increased binding of Env trimers to IgG1b12 and CD4-IgG2 and was independent of gp120 shedding. Our data highlighted vulnerabilities in the Env obtained from cross neutralizing plasma associated with the exposure of discontinuous neutralizing epitopes and enhanced autologous neutralization. Such information may aid in Env-based vaccine immunogen design. |
format | Online Article Text |
id | pubmed-3463516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34635162012-10-09 Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization Ringe, Rajesh Das, Lipsa Choudhary, Ipsita Sharma, Deepak Paranjape, Ramesh Chauhan, Virander Singh Bhattacharya, Jayanta PLoS One Research Article Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naïve chronically infected Indian patient (ID50 >600-fold higher compared to other autologous env clones). The enhanced autologous neutralization of pseudotyped viruses expressing the sensitive envelope (Env) was associated with increased sensitivity to reagents and monoclonal antibodies targeting distinct sites in Env. Chimeric viruses constructed by swapping fragments of sensitive Env into resistant Env backbone revealed that the presence of unique residues within C2V3 region of gp120 governed increased neutralization. The enhanced virus neutralization was also associated with low CD4 dependence as well as increased binding of Env trimers to IgG1b12 and CD4-IgG2 and was independent of gp120 shedding. Our data highlighted vulnerabilities in the Env obtained from cross neutralizing plasma associated with the exposure of discontinuous neutralizing epitopes and enhanced autologous neutralization. Such information may aid in Env-based vaccine immunogen design. Public Library of Science 2012-10-03 /pmc/articles/PMC3463516/ /pubmed/23056416 http://dx.doi.org/10.1371/journal.pone.0046713 Text en © 2012 Ringe et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Ringe, Rajesh Das, Lipsa Choudhary, Ipsita Sharma, Deepak Paranjape, Ramesh Chauhan, Virander Singh Bhattacharya, Jayanta Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization |
title | Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization |
title_full | Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization |
title_fullStr | Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization |
title_full_unstemmed | Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization |
title_short | Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization |
title_sort | unique c2v3 sequence in hiv-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463516/ https://www.ncbi.nlm.nih.gov/pubmed/23056416 http://dx.doi.org/10.1371/journal.pone.0046713 |
work_keys_str_mv | AT ringerajesh uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT daslipsa uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT choudharyipsita uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT sharmadeepak uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT paranjaperamesh uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT chauhanvirandersingh uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT bhattacharyajayanta uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization |